盘前异动：Moderna跌近2%，公司CEO称现有疫苗对Omicron效果远不如之前
英为财情Investing.com -周二美股盘前，Moderna Inc (NASDAQ:MRNA)跌近2%，报363.00美元。
周二，Moderna首席执行官Stéphane Bancel表示，现有疫苗在应对变异毒株Omicron效果将远不如之前，制药公司将需要数月时间，才能大规模生产新的针对该毒株的疫苗。
【本文来自英为财情Investing.com，阅读更多请登录cn.Investing.com或英为财情 App】
推荐阅读
美债、黄金告诉你，恐慌过头了！
“毒王”来袭，医药板块谁是大赢家？
Omicron会不会影响美联储的加息步伐？
恒指几乎破净，大量资金逢低布局，什么信号？券商：看好港股估值和盈利修复空间
（编辑：陈涵）
More Stories
Oil inches higher as Middle East tensions heat up
© Reuters. Army soldier miniatures and stock graph are seen in this illustration taken October 9, 2023. REUTERS/Dado Ruvic/Illustration/File Photo...
Asian stocks rise before US CPI; Japan’s Nikkei extends rally
. JP225 +1.88% Add to/Remove from Watchlist Add to Watchlist Add Position Position added successfully to: + Add another position...
SEC approves spot Bitcoin ETFs
. SEC approves spot bitcoin ETFs BTC/USD +1.76% Add to/Remove from Watchlist Add to Watchlist Add Position Position added successfully...
Google lays off hundreds in Assistant, hardware, engineering teams
© Reuters. The Google logo is seen on the Google house at CES 2024, an annual consumer electronics trade show,...
US SEC approves bitcoin ETFs in watershed for crypto market
© Reuters. FILE PHOTO: FILE PHOTO: U.S. Securities and Exchange Commission logo and representations of cryptocurrency are seen in this...
Amazon has not offered remedies to EU concerns over iRobot deal
© Reuters. FILE PHOTO: The logo of Amazon is seen at the company's logistics centre in Boves, France, October 6,...